scholarly journals Management of hipovascular non-union of ulna with implant destabilization in patient treated due to both forearm bone shafts fracture – a case report

2021 ◽  
Vol 86 (1) ◽  
pp. 7-12
Author(s):  
Adam Łazarski ◽  
◽  
Robert Stępień ◽  
Agnieszka Krasuska-Matysek

A clinical case report of a 26-year-old patient with an open fracture of both forearm shafts without known comorbidities, who, during treatment, developed a non-union of the ulna with destabilization of the implants. After another fracture stabilization procedure, debridgement of the fracture ends and filling the bone gap with frozen allogenic bone grafts, union was obtained. In this paper, the authors consider possible causes of fracture healing problems in this patient based on the available literature.

Author(s):  
Sujoy Kundu

<p class="abstract">Impaired healing of fractures delays the rehabilitation process, which in turn impacts quality of life. The associated costs cause an economic burden to both the society and the patients. Till date, no systemic treatment is approved for fracture healing. Teriparatide is a synthetic polypeptide hormone consisting of the 1–34 fragment of human parathyroid hormone. Apart from its recognized indication of osteoporosis, there is a growing body of evidence suggesting its ability to accelerate fracture healing and heal non-unions. The purpose of this case report is to elucidate the Indian experience of 5 cases of use of Teriparatide for fracture healing - delayed unions and non-unions and in the setting of osteoporotic fracture. The primary observation of our case report depicts that teriparatide is a viable therapy not only to treat osteoporosis but also to accelerate fracture healing. Teriparatide therapy accelerates healing, which allows patients to return to normal life and work faster, optimizes medical resource utilization, reduces chances for future second surgery, requirement of bone graft and overall chronic morbidity associated with long-term treatment. The advantages of teriparatide therapy are that it can be prescribed in any types of fractures, including those that will be treated non-surgically; it can be commenced at any time, and can be applied through the entire healing period. Our observations are in line with other studies showing the effects of Teriparatide on delayed union and non-unions in human subjects.</p>


2014 ◽  
Vol 45 (S 01) ◽  
Author(s):  
L. Voges ◽  
G. Stettner ◽  
D. Weise ◽  
K. Brockmann ◽  
J. Gärtner ◽  
...  

2018 ◽  
Author(s):  
Tatiana Tarasova ◽  
Alexander Lutsenko ◽  
Elena Przhiyalkovskaya ◽  
Ekaterina Pigarova ◽  
Larisa Dzeranova ◽  
...  
Keyword(s):  

2012 ◽  
Vol 2 (5) ◽  
pp. 415-417
Author(s):  
Dr. Bansi M Bhusari ◽  
◽  
Dr. Shruti Sura ◽  
Dr. Kalpan Desai ◽  
Dr. Ridhima Mahajan
Keyword(s):  

2018 ◽  
Vol 64 (5) ◽  
pp. 47-52
Author(s):  
Davor Mijatovic ◽  
Sanda Smud Orehovec ◽  
Tomislav Dapic ◽  
Vilena Vrbanovic Mijatovic
Keyword(s):  

Author(s):  
И.А. Синельникова ◽  
И.В. Сопрунова ◽  
О.П. Николаева

В статье представлено описание семейного случая миотонической дистрофии Россолимо-Штейнерта-Куршмана-Баттена. Диагноз подтвержден в результате ДНК-диагностики: выявлено увеличенное число копий CTG-повтора гена DMPK, ответственного за развитие миотонической дистрофии. A family case report of Rossolimo-Steinert-Curschmann myotonic dystrophy is presented. An increased number of copies of CTG-repeats of the DMPK gene responsible for the development of MD, i.e., the diagnosis was confirmed by molecular genetic method.


Sign in / Sign up

Export Citation Format

Share Document